Bank of Montreal’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-15,467
| Closed | -$141K | – | 3777 |
|
|
2025
Q2 | $141K | Sell |
15,467
-695
| -4% | -$5.11K | ﹤0.01% | 2906 |
|
|
2025
Q1 | $128K | Buy |
+16,162
| New | +$118K | ﹤0.01% | 2859 |
|
|
2022
Q3 | – | Sell |
-41,421
| Closed | -$1.49K | – | 4375 |
|
|
2022
Q2 | $1.49K | Buy |
41,421
+31,713
| +327% | +$1.06M | ﹤0.01% | 2054 |
|
|
2022
Q1 | $336K | Sell |
9,708
-18,632
| -66% | -$700K | ﹤0.01% | 3123 |
|
|
2021
Q4 | $1.23M | Sell |
28,340
-169,782
| -86% | -$7.11M | ﹤0.01% | 1826 |
|
|
2021
Q3 | $8.92M | Buy |
+198,122
| New | +$9.09M | ﹤0.01% | 1356 |
|
|
2021
Q2 | – | Sell |
-3,379
| Closed | -$261K | – | 4725 |
|
|
2021
Q1 | $261K | Buy |
3,379
+80
| +2% | +$6.56K | ﹤0.01% | 2994 |
|
|
2020
Q4 | $300K | Sell |
3,299
-116
| -3% | -$8.55K | ﹤0.01% | 2997 |
|
|
2020
Q3 | $218K | Buy |
3,415
+1,598
| +88% | +$81K | ﹤0.01% | 2703 |
|
|
2020
Q2 | $79K | Buy |
1,817
+707
| +64% | +$25.7K | ﹤0.01% | 3202 |
|
|
2020
Q1 | $30K | Sell |
1,110
-1,947
| -64% | -$113K | ﹤0.01% | 3100 |
|
|
2019
Q4 | $221K | Sell |
3,057
-7,314
| -71% | -$900K | ﹤0.01% | 3107 |
|
|
2019
Q3 | $1.46M | Sell |
10,371
-4,668
| -31% | -$781K | ﹤0.01% | 1882 |
|
|
2019
Q2 | $2.75M | Buy |
15,039
+9,524
| +173% | +$1.63M | ﹤0.01% | 1494 |
|
|
2019
Q1 | $877K | Sell |
5,515
-698
| -11% | -$101K | ﹤0.01% | 2067 |
|
|
2018
Q4 | $596K | Buy |
6,213
+66
| +1% | +$7.55K | ﹤0.01% | 2096 |
|
|
2018
Q3 | $868K | Buy |
6,147
+1,105
| +22% | +$171K | ﹤0.01% | 2066 |
|
|
2018
Q2 | $789K | Buy |
5,042
+4,669
| +1,252% | +$733K | ﹤0.01% | 2122 |
|
|
2018
Q1 | $60K | Buy |
373
+37
| +11% | +$6.28K | ﹤0.01% | 3158 |
|
|
2017
Q4 | $55K | Buy |
336
+236
| +236% | +$22.9K | ﹤0.01% | 3235 |
|
|
2017
Q3 | $6K | Sell |
100
-104
| -51% | -$8.17K | ﹤0.01% | 3834 |
|
|
2017
Q2 | $16K | Sell |
204
-11,802
| -98% | -$853K | ﹤0.01% | 3608 |
|
|
2017
Q1 | $853K | Buy |
12,006
+11,837
| +7,004% | +$693K | ﹤0.01% | 1911 |
|
|
2016
Q4 | $8K | Buy |
169
+115
| +213% | +$5.42K | ﹤0.01% | 3657 |
|
|
2016
Q3 | $2K | Hold |
54
| – | – | ﹤0.01% | 3861 |
|
|
2016
Q2 | $2K | Sell |
54
-81
| -60% | -$2.7K | ﹤0.01% | 3903 |
|
|
2016
Q1 | $4K | Hold |
135
| – | – | ﹤0.01% | 3857 |
|
|
2015
Q4 | $8K | Hold |
135
| – | – | ﹤0.01% | 3672 |
|
|
2015
Q3 | $6K | Sell |
135
-1,865
| -93% | -$115K | ﹤0.01% | 3608 |
|
|
2015
Q2 | $146K | Buy |
+2,000
| New | +$129K | ﹤0.01% | 2554 |
|
Other funds holding SAGE
IA
HNB
Bank of Montreal's SAGE Position: Q3 2025 in Review
Bank of Montreal sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 15,467 shares — an estimated $141K sold.
Bank of Montreal first reported a position in SAGE in Q2 2015 and held it in 30 quarters. The position peaked at $8.92M in Q3 2021. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.
- Bank of Montreal reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
- Bank of Montreal sold 15,467 Sage Therapeutics shares in Q3 2025, an estimated $141K.
- Bank of Montreal first reported a position in Sage Therapeutics in Q2 2015 and held it in 30 quarters.
- Bank of Montreal's Sage Therapeutics position peaked at $8.92M in Q3 2021.
- 5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.
Based on Bank of Montreal's 13F filing for Q3 2025, filed 13 Nov 2025.